A Washington D.C.-based biotech is causing quite the stir so far during Wednesday’s premarket after the company’s Fanapt received FDA approval for the acute treatment...

To read the full story on AllPennyStocks.com, click here.

Vanda Pharmaceuticals (NASDAQ:VNDA)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Vanda Pharmaceuticals.
Vanda Pharmaceuticals (NASDAQ:VNDA)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Vanda Pharmaceuticals.